関連する実験動画
Updated: May 7, 2026

16:49
Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
11.2K
C型肝炎ウイルスの複製をゲノムから機能まで解き放つ
Brett D Lindenbach1, Charles M Rice
1Center for the Study of Hepatitis C, The Rockefeller University, 1230 York Avenue, New York, New York 10021, USA.
Nature
|August 19, 2005
まとめ
科学者たちは,課題にもかかわらず,C型肝炎ウイルス (HCV) の理解において進歩を遂げました. 現在,HCVに対する新しい抗ウイルス療法が臨床試験中であり,治療への希望をもたらしています.
科学分野:
- ウイルス学 ウイルス学 ウイルス学
- 肝臓病理学 肝臓病理学
- 感染症 感染症は感染症です.
背景:
- 15年以上前にC型肝炎ウイルス (HCV) が発見されたことで,診断,病原産,治療に関する研究が始まりました.
- 研究は,複製のための限られた宿主範囲 (人間/チンパンジー) と効率的な細胞培養モデルがないため,大きな障害に直面しました.
研究 の 目的:
- C型肝炎ウイルスの理解と対策における進展を要約する.
- HCVに対する新しい抗ウイルス治療法の開発を強調する.
主な方法:
- C型肝炎ウイルスの研究に関する科学文献のレビュー.
- HCVの複製と薬物開発における課題の分析.
主要な成果:
- 初期的な困難にもかかわらず,HCV研究において重要な進歩が達成されました.
- HCVを標的とする第一世代の抗ウイルス薬は,臨床試験に成功した.
結論:
- C型肝炎ウイルスの研究と治療法の開発において,苦労した進歩が示されています.
- 新興の抗ウイルス薬は,HCV感染の管理における重要な前進を意味します.
関連する概念動画
Retrovirus Life Cycles
43.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
43.1K
Restarting Stalled Replication Forks
5.1K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.1K
Size and Structure of Viral Genomes
1.2K
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
1.2K
Viruses with RNA Genomes
1.5K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.5K
Hepatitis
99
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
99
Viral Hepatitis I: Introduction
28
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
28

